SWS Partners Raises Stock Holdings in Xylem Inc. $XYL

SWS Partners grew its stake in Xylem Inc. (NYSE:XYL) by 6.3% during the 2nd quarter, Holdings Channel reports. The fund owned 7,221 shares of the industrial products company’s stock after acquiring an additional 428 shares during the period. SWS Partners’ holdings in Xylem were worth $934,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in XYL. Vanguard Group Inc. lifted its position in Xylem by 1.3% during the first quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company’s stock worth $3,465,122,000 after buying an additional 362,127 shares during the period. Swedbank AB lifted its position in Xylem by 13.9% during the second quarter. Swedbank AB now owns 4,366,932 shares of the industrial products company’s stock worth $564,906,000 after buying an additional 531,890 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in Xylem by 7.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 4,024,500 shares of the industrial products company’s stock worth $480,767,000 after buying an additional 274,123 shares during the period. Price T Rowe Associates Inc. MD lifted its position in Xylem by 689.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company’s stock worth $443,074,000 after buying an additional 3,239,203 shares during the period. Finally, Northern Trust Corp lifted its position in Xylem by 2.9% during the first quarter. Northern Trust Corp now owns 3,362,993 shares of the industrial products company’s stock worth $401,743,000 after buying an additional 94,560 shares during the period. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Price Performance

Shares of XYL opened at $143.03 on Monday. The firm has a market cap of $34.82 billion, a price-to-earnings ratio of 37.15, a PEG ratio of 2.47 and a beta of 1.09. The stock has a 50 day moving average of $140.36 and a 200-day moving average of $128.64. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 52 week low of $100.47 and a 52 week high of $145.33.

Xylem (NYSE:XYL) last issued its earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, topping the consensus estimate of $1.15 by $0.11. The company had revenue of $2.30 billion during the quarter, compared to analyst estimates of $2.20 billion. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The business’s revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the firm earned $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, analysts forecast that Xylem Inc. will post 4.65 EPS for the current year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Thursday, August 28th were issued a $0.40 dividend. The ex-dividend date of this dividend was Thursday, August 28th. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. Xylem’s dividend payout ratio (DPR) is 41.56%.

Analyst Ratings Changes

Several research firms recently weighed in on XYL. Barclays began coverage on Xylem in a research report on Friday, September 19th. They set an “overweight” rating and a $165.00 target price on the stock. Wall Street Zen upgraded Xylem from a “hold” rating to a “buy” rating in a report on Saturday, August 9th. Citigroup restated a “buy” rating and issued a $152.00 price objective (up from $137.00) on shares of Xylem in a report on Monday, July 14th. Stifel Nicolaus raised their price objective on Xylem from $162.00 to $175.00 and gave the stock a “buy” rating in a report on Friday, August 1st. Finally, TD Cowen increased their target price on Xylem from $125.00 to $130.00 and gave the company a “hold” rating in a research note on Tuesday, August 26th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $152.33.

Insider Activity

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the sale, the chief accounting officer owned 2,957 shares of the company’s stock, valued at approximately $413,861.72. This trade represents a 25.27% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.27% of the company’s stock.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.